Evaluation of Skin Alterations and Epidermal Barrier Integrity in Patients Undergoing Pharmacological Cancer Treatments (EOSIN) and Wellbeing Oncological Survey (WOS): an Integrated Approach to Assessing Dermatological Effects and Quality of Life in Oncology Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07869186

Title field or adapter rule

{'original_value': 'Evaluation of Skin Alterations and Epidermal Barrier Integrity in Patients Undergoing Pharmacological Cancer Treatments (EOSIN) and Wellbeing Oncological Survey (WOS): an Integrated Approach to Assessing Dermatological Effects and Quality of Life in Oncology Patients', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.792034+00:00

Published At

2026-10-09T00:00:00+00:00

Record Updated At

2026-10-09

Source Retrieved At

2026-10-31T22:19:02.163121+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Breast Cancer", "Ovarian Cancer", "NSCLC (Non-small Cell Lung Cancer)", "Melanoma (Skin Cancer)", "Gynecological Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-09", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07869186"

protocolSection.identificationModule.officialTitle

"Evaluation of Skin Alterations and Epidermal Barrier Integrity in Patients Undergoing Pharmacological Cancer Treatments (EOSIN) and Wellbeing Oncological Survey (WOS): an Integrated Approach to Assessing Dermatological Effects and Quality of Life in Oncology Patients"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Breast Cancer (protocolSection.conditionsModule.conditions)
• Ovarian Cancer (protocolSection.conditionsModule.conditions)
• NSCLC (Non-small Cell Lung Cancer) (protocolSection.conditionsModule.conditions)
• Melanoma (Skin Cancer) (protocolSection.conditionsModule.conditions)
• Gynecological Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['skin barrier integrity assessment'], 'description': 'Assessment of skin barrier integrity, quantified by transepidermal water loss (TEWL) measured under standardized conditions', 'name': 'skin barrier assessment', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.